07/15/2026
Heart Health Update
New Advances in Cardiovascular Prevention and Treatment
Summer 2026
Cardiovascular medicine continues to evolve at an exciting pace. Many of the newest therapies are designed not only to treat heart disease but also to prevent heart attacks, strokes, heart failure, and other complications before they occur. Below are some of the most important developments that may benefit many of our patients.
Cholesterol: Lower Is Better
Research continues to confirm that lowering LDL (“bad”) cholesterol substantially reduces the risk of heart attack and stroke. While statins remain the cornerstone of therapy, several newer medications are helping patients achieve lower LDL levels than ever before.
PCSK9 inhibitors (such as evolocumab and alirocumab) can reduce LDL cholesterol by approximately 60% and have been shown to lower the risk of heart attack and stroke in patients at high cardiovascular risk.
Inclisiran is a newer injectable medication that works by silencing the production of PCSK9 in the liver. It is administered only twice a year after the initial doses, making it an attractive option for patients who have difficulty taking daily medications.
Bempedoic acid is an oral medication for patients who cannot tolerate statins or who require additional LDL reduction. Recent studies have demonstrated significant reductions in cardiovascular events.
Elevated Lipoprotein(a): An Important Hidden Risk Factor
Many people inherit high levels of Lipoprotein(a), or Lp(a), which increases the risk of premature coronary artery disease and aortic valve disease.
A simple blood test performed once during adulthood can identify elevated Lp(a). Several highly promising medications specifically targeting Lp(a) are currently in late-stage clinical trials and may become available in the near future.
Triglycerides Matter Too
Elevated triglycerides contribute to cardiovascular risk.
For selected high-risk patients with elevated triglycerides despite statin therapy, icosapent ethyl, a purified prescription omega-3 fatty acid, has been shown to reduce cardiovascular events.
Maintaining a healthy weight, limiting refined carbohydrates and alcohol, exercising regularly, and controlling diabetes remain the most effective ways to improve triglyceride levels.
New Treatments for Obesity
Excess weight is now recognized as a major driver of heart disease, diabetes, atrial fibrillation, heart failure, and sleep apnea.
New medications such as semaglutide and tirzepatide have transformed obesity treatment by producing substantial and sustained weight loss. In addition to weight reduction, these medications have been shown to reduce cardiovascular events in appropriate patients and improve blood pressure, blood sugar, and overall cardiovascular health.
Diabetes Medications That Protect the Heart
Several diabetes medications now provide benefits far beyond lowering blood sugar.
SGLT2 inhibitors have been shown to:
* Reduce hospitalization for heart failure
* Slow progression of kidney disease
* Improve survival in patients with heart failure
GLP-1 receptor agonists reduce cardiovascular events while promoting meaningful weight loss.
Many patients without diabetes may also benefit from these medications under certain circumstances.
Heart Failure Treatments Continue to Improve
Modern treatment of heart failure has changed dramatically over the past decade.
Current guideline-directed medical therapy often combines:
* ARNI therapy (sacubitril/valsartan)
* Beta-blockers
* Mineralocorticoid receptor antagonists
* SGLT2 inhibitors
Together, these therapies have significantly improved survival, reduced hospitalizations, and enhanced quality of life.
Treating Atrial Fibrillation Earlier
New evidence supports earlier rhythm-control strategies for many patients with atrial fibrillation.
Catheter ablation is increasingly being used earlier in the disease course and has become safer and more effective than ever before in appropriately selected patients.
Coronary Artery Calcium (CAC) Scoring
A coronary calcium scan is a simple, noninvasive CT scan that measures calcium within the coronary arteries.
For many patients with intermediate cardiovascular risk, CAC scoring helps personalize treatment decisions regarding statins and other preventive therapies.
Blood Pressure Goals
Current recommendations continue to emphasize maintaining blood pressure below 130/80 mmHg for most adults at increased cardiovascular risk.
Home blood pressure monitoring remains one of the most valuable tools for managing hypertension.
Smoking Cessation Remains the Most Powerful Prevention Strategy
No medication or procedure provides greater cardiovascular benefit than quitting smoking.
Smoking cessation rapidly lowers the risk of heart attack, stroke, peripheral artery disease, and sudden cardiac death. If you smoke, please let us know—we have effective medications, ni****ne replacement therapies, and counseling resources to help you succeed.
Healthy Lifestyle Still Matters
Although new medications are making tremendous advances, the foundation of cardiovascular prevention remains unchanged:
* Follow a Mediterranean-style diet rich in vegetables, fruits, whole grains, legumes, nuts, and healthy fats.
* Exercise at least 150 minutes each week.
* Maintain a healthy weight.
* Sleep 7–9 hours nightly.
* Control blood pressure, cholesterol, and diabetes.
* Avoid to***co and va**ng.
* Limit alcohol consumption.
* Manage stress and maintain regular follow-up with your healthcare team.
Looking Ahead
The future of cardiovascular medicine is increasingly personalized. Advances in genetics, imaging, artificial intelligence, and targeted therapies are allowing us to identify risk earlier and tailor treatment to each individual patient.
Our goal is not simply to treat heart disease—it is to prevent it.
If you have questions about whether any of these new treatments may be appropriate for you, please schedule an appointment. We are committed to helping you understand the latest evidence and develop a prevention plan that fits your individual needs.
Wishing you good health,
Joseph Tartaglia, MD
Cardiology
